Karahan, L., Akyildiz, A., Sahin, T. K., Batu, M. A., Ersan, C., Onur, M. R., . . . Guven, D. C. (2026). Prognostic Value of Baseline Sarcopenia and Adipose Tissue Indices in HR+/HER2− Metastatic Breast Cancer Treated with CDK4/6 Inhibitors: A Retrospective Cohort Study. Journal of Clinical Medicine, 15(4), 1623. https://doi.org/10.3390/jcm15041623
Chicago Style (17th ed.) CitationKarahan, Latif, Arif Akyildiz, Taha Koray Sahin, Mustafa Arda Batu, Cagatay Ersan, Mehmet Ruhi Onur, Sercan Aksoy, and Deniz Can Guven. "Prognostic Value of Baseline Sarcopenia and Adipose Tissue Indices in HR+/HER2− Metastatic Breast Cancer Treated with CDK4/6 Inhibitors: A Retrospective Cohort Study." Journal of Clinical Medicine 15, no. 4 (2026): 1623. https://doi.org/10.3390/jcm15041623.
MLA (9th ed.) CitationKarahan, Latif, et al. "Prognostic Value of Baseline Sarcopenia and Adipose Tissue Indices in HR+/HER2− Metastatic Breast Cancer Treated with CDK4/6 Inhibitors: A Retrospective Cohort Study." Journal of Clinical Medicine, vol. 15, no. 4, 2026, p. 1623, https://doi.org/10.3390/jcm15041623.